Divi’s Laboratories Ltd. on Thursday entered the elite club by crossing a market capitalization of Rs 1 trillion after the shares of the company hit a new high of Rs 3,832, up 3 per cent.
At 11:30 am, the stock of the pharmaceutical company was trading 2.73 per cent high at Rs 3,819.25 on NSE. It has touched a record high of Rs 3,832 per share in the early trading session and surpassed its revious high of Rs 3,763.40, touched on December 10, 2020. So far, the stock has surged 109 per cent this year. At 10:05 am, Divi’s lab’s market cap stood at Rs 1.01 trillion, as per the exchange data. 
Divi’s Lab became the second Indian pharmaceutical company to cross the milestone of Rs 1 trillion market cap after Sun Pharmaceuticals Industries, which has a market cap of Rs 1.40 trillion, as per data. Currently, Divi’s Lab stood at 30th postion among the top companies having market-cap of more than Rs 1 trillion. Divi’s Lab is known for its expanding capacities with very high business visibility and investors have been buying the stock on strong earnings from its aggressive capax plan.